Recro Pharma, Inc.

Get Full Access

Description

  • Recro Pharma is a revenue-generating, specialty pharmaceutical company focused on products for hospitals and ambulatory care settings that is currently developing non-opioid products for the treatment of acute pain. Our lead product candidate is a proprietary injectable form of meloxicam. Intravenous, (IV), meloxicam has successfully completed multiple Phase II clinical trials for the treatment of moderate to severe pain. We believe injectable meloxicam compares favorably to competitive therapies in extent of pain relief, onset of pain relief and duration of pain relief.Our pipeline also includes Dex-IN, a proprietary intranasal formulation of dexmedetomidine (Dex), which successfully completed a Phase II clinical trial in post-operative pain. Based on feedback from the FDA regarding the benefit-risk profile of Dex-IN, we plan to pursue Dex-IN in peri-procedural pain. If approved, Dex-IN would also be the first approved peri-procedural pain drug in its class of drugs.As our product candidates are non-addictive, non-opioid drugs, we believe our candidates would avoid many of the side effects associated with commonly prescribed opioid therapeutics, such as addiction, constipation and respiratory depression while maintaining meaningful analgesic effects. We believe our product candidates could provide an attractive alternative pain medication alternative to help avoid use of opioids for the more than 50 million surgical procedures that require post-operative pain medication.We currently own and operate a 97,000 square foot, DEA-licensed manufacturing facility that makes five commercial products and receives royalties associated with the sales of these products.
  • location

    Headquarters:490 Lapp Road , Malvern, Pennsylvania, United States

    More
  • Recro Pharma, Inc. phone

    Phone Number: +1 484-395-2400

  • Recro Pharma, Inc. website

    Website: https://www.recropharma.com

  • Recro Pharma, Inc. employees

    Employees:78

  • Recro Pharma, Inc. revenue

    Revenue:$10 - 50M

  • Recro Pharma, Inc. legal name

    Legal Name:Recro Pharma, Inc.

  • Recro Pharma, Inc.'s Social Media

    Recro Pharma, Inc. linkedin
  • done Is this data correct?
  • |  NAICS Code: 541715  |

    Show More
Person level website identification

Vice President, Manufacturing And Alliance Management for Recro Pharma, Inc.

Chris Sharr

Vice President, Manufacturing And Alliance Management

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Chris Sharr

Vice President, Manufacturing And Alliance Management

Cynthia Sherman

Vice President, Market Access

Christina Piantedosi

Corporate Account Director, Reimbursement

Robert Costello

Director

Joe Musciotto

Director Of Finance

Frequently Asked Questions regarding Recro Pharma, Inc.

  • Where are Recro Pharma, Inc.'s Headquarters?

    Recro Pharma, Inc.'s Headquarters are in 490 Lapp Road ,Malvern,Pennsylvania,United States

  • What is Recro Pharma, Inc.'s phone number?

    Recro Pharma, Inc.'s phone number is +1 484-395-2400

  • What is Recro Pharma, Inc.'s official website?

    Recro Pharma, Inc.'s official website is https://www.recropharma.com

  • What is Recro Pharma, Inc.'s Revenue?

    Recro Pharma, Inc.'s revenue is $10 - 50M

  • What is Recro Pharma, Inc.'s NAICS code?

    Recro Pharma, Inc.'s NAICS code is 541715

  • How many employees are working in Recro Pharma, Inc.

    Recro Pharma, Inc. has 78 employees

  • What is Recro Pharma, Inc.'s Industry?

    Recro Pharma, Inc. is in the industry of Pharmaceuticals

  • Who is Recro Pharma, Inc.'s Vice President, Manufacturing And Alliance Management?

    Recro Pharma, Inc.'s Vice President, Manufacturing And Alliance Management is Chris Sharr

Company Directory